Integrum Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 33

Employees

  • Stock Symbol
  • INTEG B

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.80
  • (As of Friday Closing)

Integrum General Information

Description

Integrum AB is a Sweden-based medical technology company specializing in osseointegrated, bone-anchored prosthetic systems for amputees. Its flagship product OPRA Implant System enables direct skeletal attachment of prosthetic limbs and is the only FDA-approved bone-anchored prosthetic implant system available in the U.S. The company operates as a single segment and generates it's key revenue from the U.S. market.

Contact Information

Website
www.integrum.se
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Gemenskapens Gata 9
  • 431 53 Molndal
  • Sweden
+46 031-760
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Gemenskapens Gata 9
  • 431 53 Molndal
  • Sweden
+46 031-760

Integrum Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integrum Stock Performance

As of 20-Nov-2026, Integrum’s stock price is $0.80. Its current market cap is $21.3M with 26.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.80 $0.81 $0.70 - $1.27 $21.3M 26.7M 47.2K -$0.15

Integrum Financials Summary

As of 31-Jul-2026, Integrum has a trailing 12-month revenue of $10.4M.

In Thousands,
USD
TTM 31-Jul-2026 FY 2026 30-Apr-2026 FY 2025 30-Apr-2025 FY 2024 30-Apr-2024
EV 21,752 19,601 29,216 94,371
Revenue 10,436 9,723 8,618 9,783
EBITDA (2,851) (3,656) (3,366) 815
Net Income (3,788) (4,930) (2,915) 379
Total Assets 20,869 21,868 21,037 15,067
Total Debt 287 341 502 587
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Integrum Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Integrum‘s full profile, request access.

Request a free trial

Integrum Patents

Integrum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2908716-T3 Anchorage system to fix a prosthesis to a long bone of the human body Active 08-Nov-2016
AU-2017356780-A1 Anchoring system for attaching a prosthesis to a human body Active 08-Nov-2016
AU-2017356780-B2 Anchoring system for attaching a prosthesis to a human body Active 08-Nov-2016
EP-3538017-A1 Anchoring system for attaching a prosthesis to a human body Active 08-Nov-2016
EP-3538017-A4 Anchoring system for attaching a prosthesis to a human body Active 08-Nov-2016 A61F2/78
To view Integrum’s complete patent history, request access »

Integrum Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integrum Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Integrum‘s full profile, request access.

Request a free trial

Integrum Acquisitions (1)

Integrum’s most recent deal was a Merger/Acquisition with Pericardium. The deal was made on 01-Jan-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pericardium 01-Jan-2018 Merger/Acquisition Therapeutic Devices
To view Integrum’s complete acquisitions history, request access »

Integrum ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Integrum’s complete esg history, request access »

Integrum Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Integrum Sweden Molndal, Sweden 2022

Integrum FAQs

  • When was Integrum founded?

    Integrum was founded in 1998.

  • Where is Integrum headquartered?

    Integrum is headquartered in Molndal, Sweden.

  • What is the size of Integrum?

    Integrum has 33 total employees.

  • What industry is Integrum in?

    Integrum’s primary industry is Therapeutic Devices.

  • Is Integrum a private or public company?

    Integrum is a Public company.

  • What is Integrum’s stock symbol?

    The ticker symbol for Integrum is INTEG B.

  • What is the current stock price of Integrum?

    As of 20-Nov-2026 the stock price of Integrum is $0.80.

  • What is the current market cap of Integrum?

    The current market capitalization of Integrum is $21.3M.

  • What is Integrum’s current revenue?

    The trailing twelve month revenue for Integrum is $10.4M.

  • What is Integrum’s annual earnings per share (EPS)?

    Integrum’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process